Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion type Assertion NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_head.
- NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion description "[In addition, we report several novel effects of deactivators and infection on the expression of known genes: (1) IL-4 caused pronounced upregulation of ABCG2, coding for an ATP-binding cassette transporter highly expressed in the placenta, which mediates multidrug resistance of cancer cells, but is otherwise of unknown function; (2) both DEX and IL-4 downregulated osteopontin, an important factor of host resistance against intracellular infections; (3) inhibition of the CC-chemokine I-309 mRNA expression by all three deactivators in the presence of Listeria infection, and (4) upregulation by Listeria infection of the interferon-stimulated gene ISG20 of unknown function, whose product localizes with nuclear dots/PML bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_provenance.
- NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion evidence source_evidence_literature NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_provenance.
- NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion SIO_000772 11345586 NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_provenance.
- NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion wasDerivedFrom befree-20140225 NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_provenance.
- NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_assertion wasGeneratedBy ECO_0000203 NP506156.RAvMOQmYFytyrGfUOUQe3fw0Z6EtI-7s0dAeJmfCR0FDg130_provenance.